E Kánitz - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

E Kánitz

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Therapia Hungarica (English Edition)|January 1, 1971

Double blind test with BaltixA Károlyi, E Kánitz, O Schweiger, et al.

Oncology|January 1, 1992

Randomized phase II trial of high-dose 4'-epi-doxorubicin + cyclophosphamide versus high-dose 4'-epi-doxorubicin + cisplatin in previously untreated patients with extensive small cell lung cancerE Kánitz, K Kolaric, J Jassem, et al.

Medical Oncology and Tumor Pharmacotherapy|January 1, 1990

Phase II study of 4'-epi-doxorubicin in patients with untreated, extensive small cell lung cancer. South-East European Oncology Group (SEEOG)S Eckhardt, K Kolaric, D Vukas, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Therapia Hungarica (English Edition)|January 1, 1971

Double blind test with BaltixA Károlyi, E Kánitz, O Schweiger, et al.

Oncology|January 1, 1992

Randomized phase II trial of high-dose 4'-epi-doxorubicin + cyclophosphamide versus high-dose 4'-epi-doxorubicin + cisplatin in previously untreated patients with extensive small cell lung cancerE Kánitz, K Kolaric, J Jassem, et al.

Medical Oncology and Tumor Pharmacotherapy|January 1, 1990

Phase II study of 4'-epi-doxorubicin in patients with untreated, extensive small cell lung cancer. South-East European Oncology Group (SEEOG)S Eckhardt, K Kolaric, D Vukas, et al.

Pageof 1